EUVIMEDEUVIMED entdecken
Crossref

68 Ga-FAPI PET/CT as an Alternative to 18 F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma

Ertan Sahin, Tulay Kus, Alper Aytekin, Evren Uzun, Umut Elboga, Latif Yilmaz, Yusuf B Cayirli, Merve Okuyan, Vuslat Cimen, Ufuk Cimen

Journal of Nuclear Medicine · 2024-04 · 65 (4) · 512-519

DOI: 10.2967/jnumed.123.266798 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 14.03.2024. Verfasst von Ertan Sahin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Gaziantep University, Gaziantep, Turkey; er_ahin@yahoo.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Quinolines. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate staging of invasive lobular carcinoma (ILC), a subtype of breast cancer, is vital for effective clinical management. Although 18F-FDG PET/CT is a commonly used tool, its efficacy varies across different histologic subtypes. To mitigate this challenge, our investigation delves into the potential utility of 68Ga-fibroblast activation protein inhibitor (FAPI) PET/CT as an alternative for staging ILC, aiming to address a significant research gap using a more expansive patient cohort than the smaller samples commonly found in the existing literature.

Methods

In this retrospective analysis, women diagnosed with primary ILC of the breast underwent both 18F-FDG PET/CT and 68Ga-FAPI PET/CT. Both modalities were compared across all lesion locations with the used reference standard. The interval between scans was 1 wk, without any intervening treatments. Lesions were categorized visually, and tracer activity was analyzed using SUVmax, tumor-to-background uptake ratio, and uptake ratios. Both modalities were compared across various parameters, and statistical analysis was performed using SPSS 22.0. A P value of less than 0.05 was chosen to determine statistical significance.

Results

The study included 23 female ILC patients (mean age, 51 y) with hormone-positive, human epidermal growth factor receptor type 2-negative tumors. Most (65%) had the luminal A subtype. 68Ga-FAPI PET/CT outperformed 18F-FDG PET/CT, with higher tumoral activity and tumor-to-background uptake ratios (P < 0.001). Primary tumors showed significantly increased uptake with 68Ga-FAPI PET/CT (P < 0.001), detecting additional foci, including multicentric cancer. Axillary lymph node metastases were more frequent and had higher uptake values with 68Ga-FAPI PET/CT (P = 0.012). Moreover, 68Ga-FAPI PET/CT identified more lesions, including bone and liver metastases. Pathologic features did not significantly correlate with imaging modalities, but a positive correlation was observed between peritumoral lymphocyte ratio and 68Ga-FAPI PET/CT-to-18F-FDG PET/CT uptake ratios (P = 0.026).

Conclusion

This study underscores 68Ga-FAPI PET/CT's superiority over 18F-FDG PET/CT for ILC. 68Ga-FAPI PET/CT excels in detecting primary breast masses, axillary lymph nodes, and distant metastases; can complement 18F-FDG PET/CT in ILC; and holds potential as an alternative imaging method in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsQuinolinesFemaleHumansMiddle AgedPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Gallium RadioisotopesRetrospective StudiesPositron-Emission Tomography

Stichwörter der Autor:innen

18F-FDG PET/CT68Ga-FAPI-PET/CTlobular breast carcinoma

Substanzen

Fluorodeoxyglucose F18Gallium RadioisotopesQuinolines

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Gaziantep University, Gaziantep, Turkey; er_ahin@yahoo.com.
  • Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey.
  • Department of General Surgery, Gaziantep University, Gaziantep, Turkey; and.
  • Department of Pathology, Gaziantep University, Gaziantep, Turkey.
  • Department of Nuclear Medicine, Gaziantep University, Gaziantep, Turkey.

Zitieren

APA

Sahin, E., Kus, T., Aytekin, A., Uzun, E., Elboga, U., Yilmaz, L., Cayirli, Y. B., Okuyan, M., Cimen, V., & Cimen, U. (2024). 68 Ga-FAPI PET/CT as an Alternative to 18 F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma. Journal of Nuclear Medicine, 65(4), 512-519. https://doi.org/10.2967/jnumed.123.266798

Vancouver

Sahin E, Kus T, Aytekin A, Uzun E, Elboga U, Yilmaz L, et al. 68 Ga-FAPI PET/CT as an Alternative to 18 F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma. Journal of Nuclear Medicine. 2024;65(4):512-519. doi:10.2967/jnumed.123.266798

BibTeX
@article{Sahin2024,
  author = {Sahin, Ertan and Kus, Tulay and Aytekin, Alper and Uzun, Evren and Elboga, Umut and Yilmaz, Latif and Cayirli, Yusuf B and Okuyan, Merve and Cimen, Vuslat and Cimen, Ufuk},
  title = {68 Ga-FAPI PET/CT as an Alternative to 18 F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  volume = {65},
  number = {4},
  pages = {512--519},
  doi = {10.2967/jnumed.123.266798}
}
Kostenlos starten →